Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

ONE DAY left in this Mid-Year Campaign. This is our hour of need.
If you value independent journalism, please support Common Dreams.

Join the small group of generous readers who donate, keeping Common Dreams free for millions of people each year. Without your help, we won’t survive.

Rep. Pramila Jayapal (D-Wash.) speaks during an oversight hearing in the Rayburn House Office Building on Capitol Hill February 8, 2019 in Washington, D.C. (Photo: Chip Somodevilla/Getty Images)

'Greed Is a Danger to Public Health': Progressive Caucus Urges Ban on Big Pharma Coronavirus Price-Gouging

"As we've seen all too often from Big Pharma, saving lives is incidental to their business model—the profit motive always comes first."

Jake Johnson

In the wake of Gilead's announcement that it will charge U.S. hospitals $3,120 per privately insured patient for a treatment course of Covid-19 drug remdesivir, the Congressional Progressive Caucus is calling on Congress to pass legislation combating the pharmaceutical industry's effort to "profiteer off a pandemic" by imposing exorbitant prices.

"This doesn't come as a surprise—after all, this is the same company that once priced a lifesaving Hepatitis C drug, Sovaldi, at $1000 per pill, totaling $84,000 for a single course of treatment," Reps. Pramila Jayapal (D-Wash.) and Mark Pocan (D-Wis.) said of Gilead in a statement Wednesday. "Sadly, as we've seen all too often from Big Pharma, saving lives is incidental to their business model—the profit motive always comes first."

"Big Pharma's greed is a danger to public health—Congress cannot allow it to go unaddressed any longer."
—Reps. Pramila Jayapal and Mark Pocan

Jayapal and Pocan urged the House Democratic leadership to hold a floor vote on Rep. Jan Schakowsky's (D-Ill.) Make Medications Affordable by Preventing Pandemic Price-Gouging Act, which would require the federal government to "mandate reasonable, affordable pricing of any new, taxpayer-funded Covid-19 drug used to diagnose, mitigate, prevent, or treat Covid-19."

"In a time of unprecedented national suffering, with more than 125,000 of our neighbors, coworkers, and loved ones dead from the coronavirus, Gilead has chosen to exploit the desperation of millions and profiteer off a pandemic," said Jayapal and Pocan. "But just because Gilead will exploit this pandemic, that doesn't mean that Congress should let them."

"Researchers have estimated that Gilead could cover the price of manufacturing remdesivir at scale with reasonable profit at a market price of $1 per day. But instead, Gilead plans to charge $520 a vial—an outrageous and unjustifiable mark-up," the lawmakers added. "Big Pharma's greed is a danger to public health—Congress cannot allow it to go unaddressed any longer."

The Progressive Caucus' demand comes as the Trump administration, as Common Dreams reported Thursday, actively opens the door to pharma price-gouging by refusing to exercise federal authority to hold down prices for coronavirus treatments developed with taxpayer money.

In several government contracts with pharmaceutical giants obtained by consumer advocacy group Knowledge Ecology International (KEI), the Trump administration left out a standard condition requiring that products developed with the help of federal funds be made available to the public "on reasonable terms."

"This means that the government has limited its ability to intervene if the pharmaceutical companies (which are party to the agreements and are receiving hundreds of millions of dollars to conduct the research) charge unreasonable prices for the resulting Covid-19 vaccines or treatments," said KEI.


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

Just ONE DAY left in our crucial Mid-Year Campaign and we might not make it without your help.
Who funds our independent journalism? Readers like you who believe in our mission: To inform. To inspire. To ignite change for the common good. No corporate advertisers. No billionaire founder. Our non-partisan, nonprofit media model has only one source of revenue: The people who read and value this work and our mission. That's it.
And the model is simple: If everyone just gives whatever amount they can afford and think is reasonable—$3, $9, $29, or more—we can continue. If not enough do, we go dark.

All the small gifts add up to something otherwise impossible. Please join us today. Donate to Common Dreams. This is crunch time. We need you now.

As US Rolls Back Reproductive Rights, Sierra Leone Moves to Decriminalize Abortion

"I'm hopeful today's announcement gives activists in the U.S., and especially Black women given the shared history, a restored faith that change is possible and progress can be made."

Brett Wilkins ·


'Indefensible': Outrage as New Reporting Shines Light on Biden Deal With McConnell

The president has reportedly agreed to nominate an anti-abortion Republican to a lifetime judgeship. In exchange, McConnell has vowed to stop blocking two Biden picks for term-limited U.S. attorney posts.

Jake Johnson ·


Assange Makes Final Appeal Against US Extradition

"If Julian Assange is not free, neither are we," said a protester at a Friday demonstration against the WikiLeaks founder's impending transfer. "None of us is free."

Brett Wilkins ·


'Payoff for 40 Years of Dark Money': Supreme Court Delivers for Corporate America

"It was the conservative court's larger agenda to gut the regulatory state and decimate executive powers to protect Americans' health and safety," warned one expert.

Jake Johnson ·


NARAL Pro-Choice Endorses Fetterman—Who Vows to End Senate Filibuster to Protect Abortion Rights

"We know we can count on him to boldly fight for abortion rights and access," said the head of one of the nation's largest reproductive rights advocacy groups.

Jon Queally ·

Common Dreams Logo